Topical AMTX-100 Proves Safe, Effective for Atopic Dermatitis in Phase 1 Trial
New data show the novel investigative drug from Amytrx was associated with 37% improvement in atopic dermatitis body surface area.
Upadacitinib 30 mg Tops Atopic Dermatitis Systemic Therapies in Meta-Analyses
Updated analysis of more than a dozen clinical trials assessing monotherapy systemic treatment of atopic dermatitis shows upadacitinib's highly prevalent efficacy in clearing skin.
